Comments

ANI Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does ANI Pharmaceuticals (ANIP) operate in?

ANI Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ANIPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Fri May 9th, before the market open

The most recent conference call was at 8:00 AM, 6 days ago Click to view past webcast

ANI Pharmaceuticals (ANIP) Forecast

News Earnings ANI Pharmaceuticals (ANIP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

ANI Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ANIP | Benzinga

Explore ANI Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANIP.

Open	$60.50
Close	-
Volume / Avg.	73.76K / 397.12K
Day Range	$59.75 - $61.07
52 Wk Range	52.50 - 77.00
Market Cap	$1.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	11.6%
Days to Cover	5.49

Recent News

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

ANI Pharmaceuticals Q1 revenue rose 43.4% to $197.12 million, EPS beat consensus, and 2025 guidance was raised on strong Cortrophin Gel and generics growth.

Vandana Singh

ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by Cortrophin Gel and brand expansion.

Vandana Singh

Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$60.50
Close	-
Volume / Avg.	73.76K / 397.12K
Day Range	$59.75 - $61.07
52 Wk Range	52.50 - 77.00
Market Cap	$1.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	11.6%
Days to Cover	5.49

About ANI Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It...

Got Questions? Ask

What is ANIP's 200-day MA?

How is ANIP's EBITDA trending?

What is ANIP's 5 years max drawdown?

What is ANIP's all-time high price?

What is ANIP's ROA?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy ANI Pharmaceuticals (ANIP) stock?

You can purchase shares of ANI Pharmaceuticals (NASDAQ:ANIP) through any online brokerage.

View our list of the best stock brokerages

Who are ANI Pharmaceuticals (ANIP) competitors?

Other companies in ANI Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Xeris Biopharma Holdings (NASDAQ:XERS), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).

What is the forecast, or price target, for ANI Pharmaceuticals (ANIP) stock?

ANI Pharmaceuticals has a consensus price target of $80.13.

What is the current price for ANI Pharmaceuticals (ANIP)?

The stock price for ANI Pharmaceuticals (NASDAQ: ANIP) is $60.4 last updated May 15, 2025 at 11:37 AM EDT.

Does ANI Pharmaceuticals (ANIP) pay a dividend?

There are no upcoming dividends for ANI Pharmaceuticals.

When is ANI Pharmaceuticals (NASDAQ:ANIP) reporting earnings?

ANI Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is ANI Pharmaceuticals (ANIP) going to split?

There is no upcoming split for ANI Pharmaceuticals.

What sector and industry does ANI Pharmaceuticals (ANIP) operate in?

ANI Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.